HLUN-B:CPH
H Lundbeck A/S Class B
47,80 DKK
0,00%
(0,00) 1D
16 ოქტ, 17:00:00 GMT+2 · DKK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HLUN-B...
Open
47,74 DKK
High
48,10 DKK
Low
47,46 DKK
Mkt. cap
47,05 მლრდ.
Avg. vol.
746,79 ათ.
Volume
0,00
52-wk high
48,10 DKK
52-wk low
35,30 DKK
Shares outstanding
796,59 მლნ.
No. of employees
5 ათ.
Open
47,74 DKK
High
48,10 DKK
Low
47,46 DKK
Mkt. cap
47,05 მლრდ.
Avg. vol.
746,79 ათ.
Volume
0,00
52-wk high
48,10 DKK
52-wk low
35,30 DKK
Shares outstanding
796,59 მლნ.
No. of employees
5 ათ.
News stories
From web sources and news partners
Simply Wall Street
·
6 წუთის წინ
Learn Why The Bull Case For Enphase Energy (ENPH) Could Change Following India Gateway Launch
ad-hoc-news.de
·
7 წუთის წინ
Halozyme Therapeutics stock closed at USD 121.84, 0.49 percent below its 52-week high
The Globe and Mail
·
1 საათის წინ
Ethereum Dramatically Outperformed the S&P 500 in Q3. Is It Finally Time to Load Up on Ethereum?
Yahoo Finance
·
8 საათის წინ
Wall Street’s record breakouts unravel as investors dump recent winners: Chart of the Day
Profile
H. Lundbeck A/S, commonly referred to as Lundbeck, is a Danish international pharmaceutical company engaged in the research, development, manufacturing, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at brain diseases, including depression, schizophrenia, Alzheimer's disease, Parkinson's disease and migraine. Wikipedia
About H Lundbeck A/S Class B
CEOშარლ ვან ზილ
Employees5 ათ.
Founded1915
Headquarters-
SectorPharmaceutical industry
Websitelundbeck.com